+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast to 2030- Product Image
Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast to 2030- Product Image
Sale

Artificial Intelligence in Diabetes Management Market by Device Type, Technology, End User, Deployment Mode, Type, Component - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904643
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Intelligence in Diabetes Management Market is rapidly evolving, driven by the convergence of healthcare demands and cutting-edge technological innovations. AI-powered solutions are fundamentally changing treatment paradigms in diabetes care, fostering optimized patient outcomes and streamlined clinical operations.

Market Snapshot: Artificial Intelligence in Diabetes Management Market

The Artificial Intelligence in Diabetes Management Market grew from USD 1.00 billion in 2024 to USD 1.32 billion in 2025. It is expected to continue growing at a CAGR of 30.79%, reaching USD 5.04 billion by 2030.

Scope & Segmentation

This report delivers a comprehensive analysis of the market’s core components, mapping the rapid expansion and integrating all aspects of the AI-enabled diabetes care landscape.

  • Device Type: Blood glucose meters (including noninvasive meters and self-monitoring devices), closed loop systems (fully and hybrid), continuous glucose monitors (snapshot and real-time), and insulin pumps (patch-based and traditional tubed).
  • Technology: Cloud computing in private and public deployments, decision support systems generating alerts and recommendations, mobile applications on Android and iOS, machine learning approaches (reinforcement, supervised, unsupervised learning), and predictive analytics focused on glucose trend and risk prediction.
  • End User: Clinics (diabetes-focused and general), home care (emphasizing remote and self-monitoring), hospitals (inpatient and outpatient settings), and research institutes (academic and private).
  • Deployment Mode: Cloud-based (hybrid and public cloud) and on-premise solutions (edge computing and server-based).
  • Type: Gestational diabetes (monitored through trimester-specific solutions), Type 1 (adult and juvenile onset), and Type 2 (insulin dependent and non-insulin dependent).
  • Component: Hardware (pumps, sensors, wearables) and software modules (algorithm engines, data management, user interface).
  • Regional Coverage: Americas (with focus markets including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and additional countries), and Asia-Pacific (covering China, India, Japan, and others).
  • Company Analysis: Profiles and trends for Medtronic plc, Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation, Tandem Diabetes Care, Inc., Teladoc Health, Inc., Omada Health, Inc., Senseonics Holdings, Inc., and Bigfoot Biomedical, Inc.

Key Takeaways for Decision-Makers

  • AI integration is shifting diabetes care from reactive monitoring to proactive risk anticipation, using real-time data to enable personalized treatment plans and precise clinical interventions.
  • Mobile and cloud platforms are transforming how patients and providers interact, creating streamlined workflows and facilitating data-driven insights across distributed populations.
  • The market is witnessing strong partnership trends, as medical device leaders and technology innovators collaborate to deliver unified diabetes management ecosystems with improved interoperability.
  • Regional adoption drivers vary, with robust growth in the Americas, regulatory-driven advances in Europe, and scalable, mobile-first solutions gaining traction in Asia-Pacific.
  • Customization in device design and algorithm adaptability are differentiating leaders, meeting nuanced needs in gestational, type 1, and type 2 diabetes management.
  • Organizations are prioritizing cybersecurity and data integrity as digital health ecosystems become more interconnected and as regulatory scrutiny increases globally.

Tariff Impact: Navigating New Cost Realities

Recent tariffs have introduced added supply chain costs, especially for imported sensors, pumps, and microprocessor components. Manufacturers are realigning by moving toward localized production and building regional assembly hubs to mitigate tariffs and streamline logistics. The resulting focus on operational resilience is reshaping procurement, with organizations adopting tools to monitor and adapt to these evolving trade policies. Distributors and importers are also securing alternative sourcing and forging long-term contracts to ensure continuity of care for patients reliant on AI-enabled systems.

Methodology & Data Sources

This analysis uses a combination of primary interviews with endocrinologists, diabetes educators, and technology innovators, as well as secondary research from regulatory filings, patent databases, and peer-reviewed journals. Data triangulation ensures a balanced perspective, with segmentation frameworks and quantitative modeling approaches enhancing the clarity of market insights. Confidential interviews with supply chain and reimbursement experts further refine context and accuracy.

Why This Report Matters

  • Supports C-level executives with actionable intelligence for identifying emerging opportunities across device, technology, and regional segments.
  • Enables informed strategy development by outlining critical market shifts, regulatory updates, and competitive collaboration trends in diabetes management.
  • Guides investment and partnership decisions using validated insights from expert stakeholders combined with region-specific adoption patterns.

Conclusion

Artificial intelligence is redefining diabetes management through connected devices, robust analytics, and streamlined patient engagement. Leaders leveraging adaptive, interoperable strategies are positioned to gain the greatest competitive benefit as market and regulatory landscapes evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Intelligence in Diabetes Management Market, by Device Type
8.1. Introduction
8.2. Blood Glucose Meter
8.2.1. Non Invasive Bg Meter
8.2.2. Smbg
8.3. Closed Loop System
8.3.1. Fully Closed Loop
8.3.2. Hybrid Closed Loop
8.4. Continuous Glucose Monitor
8.4.1. Intermittently Scanned Cgm
8.4.2. Real Time Cgm
8.5. Insulin Pump
8.5.1. Patch Pump
8.5.2. Tubed Pump
9. Artificial Intelligence in Diabetes Management Market, by Technology
9.1. Introduction
9.2. Cloud Computing
9.2.1. Private Cloud
9.2.2. Public Cloud
9.3. Decision Support Systems
9.3.1. Alert Generation
9.3.2. Dose Recommendation
9.4. Machine Learning
9.4.1. Reinforcement Learning
9.4.2. Supervised Learning
9.4.3. Unsupervised Learning
9.5. Mobile Applications
9.5.1. Android
9.5.2. Ios
9.6. Predictive Analytics
9.6.1. Glucose Trend Prediction
9.6.2. Risk Prediction
10. Artificial Intelligence in Diabetes Management Market, by End User
10.1. Introduction
10.2. Clinic
10.2.1. Diabetes Center
10.2.2. General Clinic
10.3. Home Care
10.3.1. Remote Monitoring
10.3.2. Self Monitoring
10.4. Hospital
10.4.1. Inpatient
10.4.2. Outpatient
10.5. Research Institute
10.5.1. Academic
10.5.2. Private
11. Artificial Intelligence in Diabetes Management Market, by Deployment Mode
11.1. Introduction
11.2. Cloud Based
11.2.1. Hybrid Cloud
11.2.2. Public Cloud
11.3. On Premise
11.3.1. Edge Computing
11.3.2. Server Based
12. Artificial Intelligence in Diabetes Management Market, by Type
12.1. Introduction
12.2. Gestational
12.2.1. First Trimester
12.2.2. Second Trimester
12.2.3. Third Trimester
12.3. Type 1
12.3.1. Adult Onset
12.3.2. Juvenile Onset
12.4. Type 2
12.4.1. Insulin Dependent
12.4.2. Non Insulin Dependent
13. Artificial Intelligence in Diabetes Management Market, by Component
13.1. Introduction
13.2. Hardware
13.2.1. Pumps
13.2.2. Sensors
13.2.3. Wearable Devices
13.3. Software
13.3.1. Algorithms
13.3.2. Data Management
13.3.3. User Interface
14. Americas Artificial Intelligence in Diabetes Management Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Artificial Intelligence in Diabetes Management Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Artificial Intelligence in Diabetes Management Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Medtronic plc
17.3.2. Abbott Laboratories
17.3.3. Dexcom, Inc.
17.3.4. F. Hoffmann-La Roche Ltd
17.3.5. Insulet Corporation
17.3.6. Tandem Diabetes Care, Inc.
17.3.7. Teladoc Health, Inc.
17.3.8. Omada Health, Inc.
17.3.9. Senseonics Holdings, Inc.
17.3.10. Bigfoot Biomedical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INVASIVE BG METER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SMBG, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FULLY CLOSED LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INTERMITTENTLY SCANNED CGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REAL TIME CGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PATCH PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TUBED PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALERT GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DOSE RECOMMENDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REINFORCEMENT LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY UNSUPERVISED LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ANDROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY IOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GLUCOSE TREND PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RISK PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DIABETES CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY EDGE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SERVER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY FIRST TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SECOND TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY THIRD TRIMESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ADULT ONSET, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY JUVENILE ONSET, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY NON INSULIN DEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY USER INTERFACE, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 140. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 141. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 150. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 152. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 153. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 154. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 155. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 157. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 159. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 160. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 161. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 163. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 164. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 165. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 166. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 167. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 168. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 169. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 171. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 172. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 173. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 174. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 175. CANADA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 176. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 177. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 178. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 179. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 180. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 181. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 183. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 185. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 187. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 189. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 190. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 191. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 193. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 194. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 195. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 197. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 198. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 199. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 200. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 201. MEXICO ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 206. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 207. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 209. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 211. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 213. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 215. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 216. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 217. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 218. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 219. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 220. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 221. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 223. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 224. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 225. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 226. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 227. BRAZIL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 228. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 229. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 230. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 231. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 232. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 233. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 235. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 237. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 238. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 239. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2018-2030 (USD MILLION)
TABLE 241. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 242. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 243. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2030 (USD MILLION)
TABLE 244. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 245. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2018-2030 (USD MILLION)
TABLE 246. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2018-2030 (USD MILLION)
TABLE 247. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GESTATIONAL, 2018-2030 (USD MILLION)
TABLE 249. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 1, 2018-2030 (USD MILLION)
TABLE 250. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TYPE 2, 2018-2030 (USD MILLION)
TABLE 251. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 252. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
TABLE 253. ARGENTINA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2018-2030 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2018-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD COMPUTING, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MACHINE LEARNING, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY MOBILE APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ARTIFI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Artificial Intelligence in Diabetes Management market report include:
  • Medtronic plc
  • Abbott Laboratories
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Teladoc Health, Inc.
  • Omada Health, Inc.
  • Senseonics Holdings, Inc.
  • Bigfoot Biomedical, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.04 Billion
Compound Annual Growth Rate30.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Glucose Monitoring System, Smart Insulin Pen), By Type (Wearable, Handheld Device), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Glucose Monitoring System, Smart Insulin Pen), By Type (Wearable, Handheld Device), By End-use (Hospitals), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Digital Diabetes Management Market by Product Type, Delivery Method, End User, Application, Sales Channel - Global Forecast to 2030 - Product Image

Digital Diabetes Management Market by Product Type, Delivery Method, End User, Application, Sales Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Artificial Intelligence in Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Artificial Intelligence in Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2024-2032 - Product Image

Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2024-2032

  • Report
  • 146 Pages
  • Global
From
Artificial Intelligence in Diabetes Management Market Report 2025 - Product Image

Artificial Intelligence in Diabetes Management Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Artificial Intelligence in Diabetes Management Market

In the field of medical devices, the Artificial Intelligence in Diabetes Management market comprises a range of technologies aimed at assisting patients with diabetes and healthcare professionals to monitor, treat, and manage the disease more effectively. These include, but are not limited to, devices such as smart glucose meters, continuous glucose monitoring systems (CGMs), insulin pumps, and automated insulin delivery systems, all of which have incorporated AI algorithms to improve functionality. The integration of AI helps in predicting glucose levels fluctuations, offering personalized dosage recommendations, and identifying patterns in blood glucose data that may indicate a need for therapeutic adjustments. AI-driven solutions in this market are designed to ease the burden of daily diabetes management tasks, reduce the incidence of hypo- and hyperglycemic events, and overall improve the quality of life for people with diabetes. Advances in machine learning, predictive analytics, and data processing have greatly enhanced the performance of such devices, leading to more autonomous and patient-tailored diabetes care. Prominent companies operating in the Artificial Intelligence in Diabetes Management market include Medtronic, which offers AI-integrated insulin pumps and CGM systems; Dexcom, known for its sophisticated CGMs; Insulet Corporation, creator of the Omnipod insulin management system; and Abbott Laboratories, the company behind the FreeStyle Libre glucose monitoring technology. Other notable players include Tandem Diabetes Care and Diabnext, which have also developed innovative AI-driven medical devices and management platforms for diabetes care. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.